Category

Litigation Update: 3M Earplugs MDL Bellwether Trials Set to Start with Issues of Expert Testimony and Juror Influence Before the Court

Posted on by Edward Lott

At a March 13 hearing in Florida federal court, two industrial hygienists were barred from testifying in the upcoming multidistrict litigation involving defective earplugs manufactured by 3M.  In their motion, plaintiffs challenged the expert testimony of two Certified Industrial Hygienists, seeking to exclude their opinions in their entirety on the grounds of qualifications, reliability and … Continue reading “Litigation Update: 3M Earplugs MDL Bellwether Trials Set to Start with Issues of Expert Testimony and Juror Influence Before the Court”

Litigation Update: New Filings on TikTok’s $92 Million Proposed Settlement Plan

Posted on by Edward Lott

On March 24th, new briefs were filed in the TikTok MDL as mandated by U.S. District Judge John Z. Lee. These fillings came in response to the judge’s questions in reference to the proposed settlement of March 2nd. The judge had requested further information about class members, appropriate representation for both adults and minors, careful … Continue reading “Litigation Update: New Filings on TikTok’s $92 Million Proposed Settlement Plan”

Paraquat Papers

Posted on by Edward Lott

Multiple lawsuits are pending in the United States alleging the weedkilling chemical paraquat causes Parkinson’s disease, and the first case to go to trial over the allegations against Syngenta over paraquat and Parkinson’s was originally scheduled for April 12 but was rescheduled for May 10 in St. Clair County Circuit Court in Illinois. The trial … Continue reading “Paraquat Papers”

As Asbestos Litigation Continues to Grow, Companies Need to Revisit Forecasts

Posted on by Edward Lott

Manufacturers and distributors of products containing asbestos, as well as the contracting firms whose tradesmen worked with materials containing the now-known carcinogen, may be at financial risk more than previously thought. The original financial risk models that were used ten or more years ago to guide those companies in planning how they would manage settlement … Continue reading “As Asbestos Litigation Continues to Grow, Companies Need to Revisit Forecasts”

Litigation Update: J&J, Imerys Ask New Jersey State Court to Throw Out Verdicts Totaling $117M

Posted on by Edward Lott

At a hearing before a New Jersey state appeals court on March 9, attorneys for Johnson & Johnson and Imerys Talc America sought to throw out verdicts totaling $117 million awarded in a case brought by Stephen Lanzo and his wife, Kendra; the plaintiffs alleged that Mr. Lanzo’s mesothelioma was caused by asbestos-contaminated talc products … Continue reading “Litigation Update: J&J, Imerys Ask New Jersey State Court to Throw Out Verdicts Totaling $117M”

Monsanto’s Campaign Against U.S. Right To Know: Read the Documents

Posted on by Edward Lott

Update 3.16.21: The Northern California Chapter of the Society for Professional Journalists honored U.S. Right to Know with the James Madison Freedom of Information Awards for our work submitting public records requests to unearth documents showing how Monsanto recruited public university professors to support its PR goals. Concerned that our research would uncover its influence in academic … Continue reading “Monsanto’s Campaign Against U.S. Right To Know: Read the Documents”

Litigation Update: Trove of Internal Documents to be Produced in Opioid Litigation

Posted on by Edward Lott

As part of a global resolution to the opioid litigation, pharmaceutical manufacturers and distributors have agreed to make public millions of pages of internal documents that detail the aggressive marketing and sales methods that fueled the epidemic.  OxyContin manufacturers Purdue Pharma LP, Insys Therapeutics Inc., Mallinckrodt PLC and consulting firm McKinsey & Co. have developed … Continue reading “Litigation Update: Trove of Internal Documents to be Produced in Opioid Litigation”

Bayer’s class action settlement plan draws widespread outrage, opposition

Posted on by Edward Lott

More than 90 law firms and more than 160 lawyers have notified a federal court judge overseeing U.S. Roundup litigation that they oppose Monsanto owner Bayer AG’s $2 billion plan to settle future claims the company expects to be brought by people diagnosed with cancer they blame on use of Monsanto’s herbicide products. In recent … Continue reading “Bayer’s class action settlement plan draws widespread outrage, opposition”

Litigation Update: Verdicts Against Bard and J&J Totaling $83M Overturned

Posted on by Edward Lott

On March 2, a three-judge appeals panel in New Jersey overturned two verdicts totaling more than $83 million against Johnson & Johnson and C.R. Bard, Inc. on the grounds that the trial court had erred by preventing the defendants from presenting certain evidence to the two juries who made the awards in 2017 and 2018. … Continue reading “Litigation Update: Verdicts Against Bard and J&J Totaling $83M Overturned”

Litigation Update: 3M Argues PFAS Lawsuit Should Go To Michigan Federal Court

Posted on by Edward Lott

In a hearing on March 2, attorneys for defendant 3M Company argued to a Michigan federal court that a lawsuit filed earlier in Michigan’s Washtenaw Circuit Court belonged in federal court since it was based in part on work done for the federal government. The state court case filed by the Michigan Attorney General in … Continue reading “Litigation Update: 3M Argues PFAS Lawsuit Should Go To Michigan Federal Court”

ForLawFirmsOnly Marketing, Inc. © 1994-2021 All Rights Reserved
Scroll Up